The mechanism of action of CPI therapy is based upon blocking of inhibitory signals transmitted from cancer cells to infiltrating immune cells (5) through the PD-L1 and CTLA-4 checkpoints, which are commonly upregulated in cancer cells. This evidence concerns the gene CTLA4 and cancer.